offering a potential novel avenue for treatment. "We are thrilled to have our first participant enrolled," said Chief Executive Officer Cheri Ackerman. "For the millions of people who suffer from ...
Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...
ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitisZORYVE, a next-generation topical phosphodiesterase-4 ...
"There is a need for Canadian health care providers, and ultimately patients, to have options for reimbursed treatments for atopic dermatitis (commonly known as eczema). Atopic dermatitis is a complex ...